Regulation of neonatal renal hemodynamics

新生儿肾脏血流动力学的调节

基本信息

项目摘要

The differences between neonatal and adult kidneys are not limited to their sizes. At birth, the newborn kidneys are functionally immature and exhibit higher vascular resistance and lower glomerular filtration rate (GFR) compared with adults. Renal immaturity put neonates at risk of kidney injury, especially when renal hemodynamics is altered by adverse perinatal events, including hypovolemia, asphyxia, sepsis, and renal ischemia. Several areas of neonatal renal hemodynamics remain unexplored. In particular, mechanisms that control neonatal renal vascular tone and pathological alterations that underlie hypoperfusion-induced acute kidney injury (AKI) are unresolved. A growing body of evidence suggests that members of the transient receptor potential (TRP) family of ion channels contribute to the intrinsic regulation of vascular tone in adults. Whether TRP channels control neonatal renal vascular resistance and hemodynamics is unclear. The present application derives from preliminary findings suggesting that the vanilloid transient receptor potential (TRPV) subfamily, member 4 is expressed in neonatal renal preglomerular artery and arteriole myocytes and regulates renal vascular tone, kidney perfusion, and GFR. Data from our pilot studies also suggest that alterations in renal vascular TRPV4 channel expression are associated with renal ischemia/reperfusion-induced neonatal AKI. The overarching hypothesis of this proposal is that TRPV4 channels regulate neonatal renal vascular resistance and hemodynamics, and that alterations in renal vascular TRPV4 channel expression and activity amplify kidney hypoperfusion in neonatal AKI. To address this hypothesis, three Specific Aims will be studied using newborn pigs. We propose to: 1) study localization of TRPV4 channels in preglomerular vascular myocytes and test the hypothesis that these channels regulate renal vascular resistance in neonates, 2) determine the functional significance of TRPV4 channels in neonatal renal regional microcirculation, GFR, and water and electrolyte homeostasis, and 3) explore the hypothesis that renal ischemia/reperfusion in neonates alters vascular myocyte TRPV4 channel expression and activity, leading to kidney hypoperfusion and AKI. This application will identify TRPV4 as an important regulator of renal functions in neonates.
新生儿和成人肾脏的差异并不局限于它们的大小。出生时,新生儿肾脏功能不成熟,与成人相比,血管阻力更高,肾小球滤过率(GFR)更低。肾不成熟使新生儿有肾损伤的危险,特别是当肾血流动力学被不良围产期事件改变时,包括低血容量、窒息、败血症和肾缺血。新生儿肾脏血流动力学的几个领域仍未被探索。特别是,控制新生儿肾血管张力的机制和低灌注诱导的急性肾损伤(AKI)的病理改变尚不清楚。越来越多的证据表明,瞬时受体电位(TRP)离子通道家族的成员参与成人血管张力的内在调节。TRP通道是否控制新生儿肾血管阻力和血流动力学尚不清楚。目前的应用源于初步研究结果,表明香兰素瞬时受体电位(TRPV)亚家族成员4在新生儿肾肾小球前动脉和小动脉肌细胞中表达,并调节肾血管张力、肾脏灌注和GFR。我们的前期研究数据还表明,肾血管TRPV4通道表达的改变与肾缺血/再灌注诱导的新生儿AKI有关。该建议的总体假设是TRPV4通道调节新生儿肾血管阻力和血流动力学,肾血管TRPV4通道表达和活性的改变放大了新生儿AKI肾灌注不足。为了解决这一假设,三个具体目标将研究使用新生猪。我们建议:1)研究肾小球前血管肌细胞中TRPV4通道的定位,验证这些通道调节新生儿肾血管阻力的假说;2)确定TRPV4通道在新生儿肾区域微循环、GFR和水电解质稳态中的功能意义;3)探讨新生儿肾脏缺血/再灌注改变血管肌细胞TRPV4通道的表达和活性,导致肾脏灌注不足和AKI的假说。该应用将确定TRPV4作为新生儿肾脏功能的重要调节因子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adebowale Adebiyi其他文献

Adebowale Adebiyi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adebowale Adebiyi', 18)}}的其他基金

Urotensin II and renal insufficiency in growth-restricted infants.
尾加压素 II 和生长受限婴儿的肾功能不全。
  • 批准号:
    10264070
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10591881
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10594479
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    10341119
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10392350
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Urotensin II and renal insufficiency in growth-restricted infants.
尾加压素 II 和生长受限婴儿的肾功能不全。
  • 批准号:
    10469433
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    9884233
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
新生儿尿路梗阻的血管离子通道与微循环
  • 批准号:
    10565955
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10201230
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:
Control of microvascular function by ion channels
离子通道控制微血管功能
  • 批准号:
    10808238
  • 财政年份:
    2020
  • 资助金额:
    $ 30万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了